Actively Recruiting
Autologous Mitochondrial Transplant for Cerebral Ischemia
Led by University of Washington · Updated on 2025-05-21
20
Participants Needed
1
Research Sites
287 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.
CONDITIONS
Official Title
Autologous Mitochondrial Transplant for Cerebral Ischemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eligible for endovascular thrombectomy to treat acute large vessel occlusion
- Eligible for angioplasty (microcatheter-based balloon, mechanical or chemical angioplasty) to treat acute cerebral vasospasm after aneurysmal subarachnoid hemorrhage
- Enough time to obtain meaningful consent from patient or legally-authorized representative
You will not qualify if you...
- Unable to receive a brain MRI scan
- Known mitochondrial disease
- Hemodynamically unstable patients who cannot safely undergo or complete standard endovascular reperfusion treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Harborview Medical Center
Seattle, Washington, United States, 98104
Actively Recruiting
Research Team
S
Study Coordinator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here